The effect of nebulised MgSO4 on lung function in stable severe asthma patients with persistent airflow limitation

A. Zandsteeg, P. Hirmann, J. P. Yska, A. Ten Brinke (Leeuwarden, Netherlands)

Source: Annual Congress 2007 - New drugs for asthma
Session: New drugs for asthma
Session type: Oral Presentation
Number: 2963
Disease area: Airway diseases

Congress or journal article abstractSlide presentationMultimedia filesE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Zandsteeg, P. Hirmann, J. P. Yska, A. Ten Brinke (Leeuwarden, Netherlands). The effect of nebulised MgSO4 on lung function in stable severe asthma patients with persistent airflow limitation. Eur Respir J 2007; 30: Suppl. 51, 2963

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Normal lung function and absence of bronchodilator response in children with stable, controlled asthma using inhaled corticosteroids
Source: Annual Congress 2006 - New features of paediatric asthma
Year: 2006


How to interpret reduced forced expiratory volume in 1 s (FEV1)/vital capacity ratio with normal FEV1
Source: Eur Respir J 2009; 33: 1396-1402
Year: 2009



The role of concomitant respiratory diseases on the rate of decline in FEV1 among adult asthmatics
Source: Eur Respir J 2003; 21: 95-10
Year: 2003



NVA237, a once-daily anticholinergic, demonstrates sustained bronchodilation and is well tolerated in patients with reversible obstructive airways disease
Source: Annual Congress 2006 - Recent advances in the treatment of COPD
Year: 2006


FEV6 or FVC to detect airway obstruction in the community setting?
Source: Annual Congress 2007 - PG17 - Lung function measurement in the community
Year: 2007



Why should we perform lung function tests?
Source: Annual Congress 2007 - PG17 - Lung function measurement in the community
Year: 2007



Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD
Source: Eur Respir J 2003; 21: 86-94
Year: 2003



sGaw as an alternative for FEV1 in the measurement of airway responsiveness to methacholine in patients experiencing chronic cough
Source: Annual Congress 2011 - Lung function today and tomorrow I
Year: 2011


Sequential evaluation of expiratory flow limitation, inspiratory muscle strength and spirometry in severe COPD exacerbations
Source: Eur Respir J 2001; 18: Suppl. 33, 149s
Year: 2001

Exercise-induced bronchoconstriction and bronchodilation: investigating the effects of age, sex, airflow limitation and FEV1
Source: Eur Respir J, 58 (2) 2004026; 10.1183/13993003.04026-2020
Year: 2021



Airway calibre variability by forced oscillation technique: a sensitive indicator of bronchodilator effect in asthmatic children
Source: Annual Congress 2005 - Monitoring paediatric asthma
Year: 2005


Lung function decline, chronic bronchitis and occupational exposures during the follow-up of the ECRHS
Source: Annual Congress 2005 - Better understanding of lung function decline and COPD
Year: 2005


FEF25-75% should not yet be used to define a bronchodilator response in individuals
Source: Annual Congress 2005 - Spirometry - now and in the future
Year: 2005


Exercise capacity, tidal expiratory flow limitation, and dyspnoea in patients with stable COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 284s
Year: 2002

Home telemonitoring (forced expiratory volume in 1 s) in children with severe asthma does not reduce exacerbations
Source: Eur Respir J 2012; 39: 290-296
Year: 2012



Exercise-induced expiratory flow limitation and exercise capacity in patients with bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 290s
Year: 2002

Airway responsiveness to hypertonic saline: dose-response slope or PD15?
Source: Eur Respir J 2005; 25: 153-158
Year: 2005